Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA.

Ann Rheum Dis. 2019 Jul 3. pii: annrheumdis-2019-215672. doi: 10.1136/annrheumdis-2019-215672. [Epub ahead of print]

PMID:
31270110
2.

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.

Aydin SZ, Robson JC, Sreih AG, Hill C, Alibaz-Oner F, Mackie S, Beard S, Gul A, Hatemi G, Kermani TA, Mahr A, Meara A, Milman N, Shea B, Tómasson G, Tugwell P, Direskeneli H, Merkel PA.

J Rheumatol. 2019 Mar 15. pii: jrheum.181072. doi: 10.3899/jrheum.181072. [Epub ahead of print]

PMID:
30877212
3.

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.

Tomasson G, Farrar JT, Cuthbertson D, McAlear CA, Ashdown S, Cronholm PF, Dawson J, Gebhart D, Lanier G, Luqmani RA, Milman N, Peck J, Robson JC, Shea JA, Carette S, Khalidi N, Koening CL, Langford CA, Monach PA, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2019 Mar 1. pii: jrheum.171405. doi: 10.3899/jrheum.171405. [Epub ahead of print]

PMID:
30824648
4.

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.

Milman N, McConville E, Robson JC, Boonen A, Tugwell P, Wells GA, Chaudhuri D, Dawson J, Tomasson G, Ashdown S, Gebhart D, Lanier G, Peck J, McAlear CA, Kellom KS, Cronholm PF, Merkel PA.

J Rheumatol. 2019 Feb 1. pii: jrheum.181073. doi: 10.3899/jrheum.181073. [Epub ahead of print]

PMID:
30709951
5.

Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study.

Tomasson G, Bjornsson J, Zhang Y, Gudnason V, Merkel PA.

Scand J Rheumatol. 2019 May;48(3):213-217. doi: 10.1080/03009742.2018.1506821. Epub 2018 Nov 21.

PMID:
30460876
6.

The association between different traumatic life events and suicidality.

Ásgeirsdóttir HG, Valdimarsdóttir UA, Þorsteinsdóttir ÞK, Lund SH, Tomasson G, Nyberg U, Ásgeirsdóttir TL, Hauksdóttir A.

Eur J Psychotraumatol. 2018 Sep 11;9(1):1510279. doi: 10.1080/20008198.2018.1510279. eCollection 2018.

7.

Association of Stress-Related Disorders With Subsequent Autoimmune Disease.

Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, Almqvist C, Fall K, Valdimarsdóttir UA.

JAMA. 2018 Jun 19;319(23):2388-2400. doi: 10.1001/jama.2018.7028.

8.

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire.

Robson JC, Dawson J, Doll H, Cronholm PF, Milman N, Kellom K, Ashdown S, Easley E, Gebhart D, Lanier G, Mills J, Peck J, Luqmani RA, Shea J, Tomasson G, Merkel PA.

Ann Rheum Dis. 2018 Aug;77(8):1157-1164. doi: 10.1136/annrheumdis-2017-212713. Epub 2018 Apr 25.

PMID:
29695498
9.

Obstetric interventions, trends, and drivers of change: A 20-year population-based study from Iceland.

Swift EM, Tomasson G, Gottfreðsdóttir H, Einarsdóttir K, Zoega H.

Birth. 2018 Dec;45(4):368-376. doi: 10.1111/birt.12353. Epub 2018 Apr 24.

PMID:
29687477
10.

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.

Robson JC, Dawson J, Cronholm PF, Milman N, Kellom KS, Ashdown S, Easley E, Farrar JT, Gebhart D, Lanier G, McAlear CA, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.

Patient Relat Outcome Meas. 2018 Jan 4;9:17-34. doi: 10.2147/PROM.S144992. eCollection 2018.

11.

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Robson JC, Dawson J, Cronholm PF, Ashdown S, Easley E, Kellom KS, Gebhart D, Lanier G, Milman N, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.

Rheumatol Int. 2018 Apr;38(4):675-682. doi: 10.1007/s00296-017-3855-6. Epub 2017 Nov 9.

12.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

13.

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Sreih AG, Alibaz-Oner F, Kermani TA, Aydin SZ, Cronholm PF, Davis T, Easley E, Gul A, Mahr A, McAlear CA, Milman N, Robson JC, Tomasson G, Direskeneli H, Merkel PA.

J Rheumatol. 2017 Dec;44(12):1933-1937. doi: 10.3899/jrheum.161467. Epub 2017 Sep 1.

14.

Determinants of Knowledge and Attitudes Regarding Pain among Nurses in a University Hospital: A Cross-sectional Study.

Gretarsdottir E, Zoëga S, Tomasson G, Sveinsdottir H, Gunnarsdottir S.

Pain Manag Nurs. 2017 Jun;18(3):144-152. doi: 10.1016/j.pmn.2017.02.200. Epub 2017 Apr 23.

PMID:
28442281
15.

Long-lasting improvements in health-related quality of life among women with chronic pain, following multidisciplinary rehabilitation.

Björnsdóttir SV, Triebel J, Arnljótsdóttir M, Tómasson G, Valdimarsdóttir UA.

Disabil Rehabil. 2018 Jul;40(15):1764-1772. doi: 10.1080/09638288.2017.1312565. Epub 2017 Apr 14.

PMID:
28407728
16.

Response to eLetter: 'Infections in giant cell arteritis and therapeutic implications' by Moiseev et al.

Rhee RL, Grayson PC, Merkel PA, Tomasson G.

Ann Rheum Dis. 2017 Sep;76(9):e30. doi: 10.1136/annrheumdis-2016-210976. Epub 2017 Jan 17. No abstract available.

PMID:
28096072
17.

Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.

Unizony S, Lu N, Tomasson G, Zhang Y, Merkel PA, Stone JH, Antonio Aviña-Zubieta J, Choi HK.

Arthritis Rheumatol. 2017 Jan;69(1):176-184. doi: 10.1002/art.39847.

18.

Infections and the risk of incident giant cell arteritis: a population-based, case-control study.

Rhee RL, Grayson PC, Merkel PA, Tomasson G.

Ann Rheum Dis. 2017 Jun;76(6):1031-1035. doi: 10.1136/annrheumdis-2016-210152. Epub 2016 Nov 28.

PMID:
27895041
19.

Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.

Mohammad AJ, Englund M, Turesson C, Tomasson G, Merkel PA.

J Rheumatol. 2017 Jan;44(1):84-90. doi: 10.3899/jrheum.160249. Epub 2016 Nov 1.

PMID:
27803140
20.

Comorbidities in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis versus the General Population.

Englund M, Merkel PA, Tomasson G, Segelmark M, Mohammad AJ.

J Rheumatol. 2016 Aug;43(8):1553-8. doi: 10.3899/jrheum.151151. Epub 2016 Jun 1.

PMID:
27252425
21.

Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.

Robson JC, Milman N, Tomasson G, Dawson J, Cronholm PF, Kellom K, Shea J, Ashdown S, Boers M, Boonen A, Casey GC, Farrar JT, Gebhart D, Krischer J, Lanier G, McAlear CA, Peck J, Sreih AG, Tugwell PS, Luqmani RA, Merkel PA.

J Rheumatol. 2015 Nov;42(11):2204-9. doi: 10.3899/jrheum.141143. Epub 2015 Sep 1. Review.

22.

Health-related quality of life improvements among women with chronic pain: comparison of two multidisciplinary interventions.

Björnsdóttir SV, Arnljótsdóttir M, Tómasson G, Triebel J, Valdimarsdóttir UA.

Disabil Rehabil. 2016;38(9):828-36. doi: 10.3109/09638288.2015.1061609. Epub 2015 Jun 30.

PMID:
26122546
23.

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

Aydin SZ, Direskeneli H, Sreih A, Alibaz-Oner F, Gul A, Kamali S, Hatemi G, Kermani T, Mackie SL, Mahr A, Meara A, Milman N, Nugent H, Robson J, Tomasson G, Merkel PA.

J Rheumatol. 2015 Dec;42(12):2465-9. doi: 10.3899/jrheum.141144. Epub 2015 Jun 15. Review.

24.

Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis.

Tomasson G.

Curr Opin Rheumatol. 2015 Jan;27(1):38-44. doi: 10.1097/BOR.0000000000000135. Review.

PMID:
25405826
25.

In response: risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis.

Tomasson G, Merkel PA.

Ann Intern Med. 2014 Aug 5;161(3):230. doi: 10.7326/L14-5015-2. No abstract available.

PMID:
25089868
26.

Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.

Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, Merkel PA.

Ann Intern Med. 2014 Jan 21;160(2):73-80.

27.

Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's).

Tomasson G, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera R, St Clair EW, Stone JH, Merkel PA.

Arthritis Rheumatol. 2014 Feb;66(2):428-32. doi: 10.1002/art.38248.

28.

Current status of outcome measure development in vasculitis.

Merkel PA, Aydin SZ, Boers M, Cornell C, Direskeneli H, Gebhart D, Hatemi G, Luqmani R, Matteson EL, Milman N, Robson J, Seo P, Tomasson G.

J Rheumatol. 2014 Mar;41(3):593-8. doi: 10.3899/jrheum.131248. Epub 2014 Jan 15.

29.

Quality of life and outcome measures in vasculitis.

Tomasson G.

Best Pract Res Clin Rheumatol. 2013 Feb;27(1):69-77. doi: 10.1016/j.berh.2013.01.003. Review.

PMID:
23507058
30.

Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.

Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Iklé D, Kallenberg CG, Krischer J, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Johnson KJ, Merkel PA.

Ann Rheum Dis. 2013 Aug;72(8):1342-50. doi: 10.1136/annrheumdis-2012-201981. Epub 2012 Sep 12.

31.

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis.

Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Hoffman GS, Merkel PA; Vasculitis Clinical Research Consortium.

Ann Rheum Dis. 2012 Aug;71(8):1329-34. doi: 10.1136/annrheumdis-2011-200795. Epub 2012 Feb 10.

32.

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.

Monach PA, Kümpers P, Lukasz A, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Carette S, Ding L, Hoffman GS, Iklé D, Kallenberg CG, Khalidi NA, Langford CA, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Haubitz M, Merkel PA.

PLoS One. 2012;7(1):e30197. doi: 10.1371/journal.pone.0030197. Epub 2012 Jan 18.

33.

Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis.

Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2012 Feb;39(2):303-9. doi: 10.3899/jrheum.110652. Epub 2011 Dec 15.

34.

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA.

Rheumatology (Oxford). 2012 Jan;51(1):100-9. doi: 10.1093/rheumatology/ker280. Epub 2011 Oct 29.

35.

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).

Tomasson G, Boers M, Walsh M, LaValley M, Cuthbertson D, Carette S, Davis JC, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, McCune WJ, Monach PA, Seo P, Specks U, Spiera R, St Clair EW, Stone JH, Ytterberg SR, Merkel PA.

Arthritis Care Res (Hoboken). 2012 Feb;64(2):273-9. doi: 10.1002/acr.20649.

36.

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.

Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA.

Arthritis Rheum. 2011 Dec;63(12):3988-97. doi: 10.1002/art.30615.

37.

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, Suppiah R, Tomasson G, Luqmani RA.

J Rheumatol. 2011 Jul;38(7):1480-6. doi: 10.3899/jrheum.110276.

38.

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Direskeneli H, Aydin SZ, Kermani TA, Matteson EL, Boers M, Herlyn K, Luqmani RA, Neogi T, Seo P, Suppiah R, Tomasson G, Merkel PA.

J Rheumatol. 2011 Jul;38(7):1471-9. doi: 10.3899/jrheum.110275.

39.

Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.

Tomasson G, Lavalley M, Tanriverdi K, Finkielman JD, Davis JC Jr, Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Stone JH, Freedman JE, Merkel PA; Wegener's Granulomatosis Etanercept Trial (WGET) Research Group.

J Rheumatol. 2011 Jun;38(6):1048-54. doi: 10.3899/jrheum.100735. Epub 2011 Mar 16.

40.

Effect of rheumatoid factor on mortality and coronary heart disease.

Tomasson G, Aspelund T, Jonsson T, Valdimarsson H, Felson DT, Gudnason V.

Ann Rheum Dis. 2010 Sep;69(9):1649-54. doi: 10.1136/ard.2009.110536. Epub 2009 Jul 23.

41.

Thromboembolic disease in vasculitis.

Tomasson G, Monach PA, Merkel PA.

Curr Opin Rheumatol. 2009 Jan;21(1):41-6. doi: 10.1097/BOR.0b013e32831de4e7. Review.

42.

Dynamics of pneumococcal carriage among healthy Icelandic children attending day-care centres.

Tomasson G, Gudnason T, Kristinsson KG.

Scand J Infect Dis. 2005;37(6-7):422-8.

PMID:
16012001

Supplemental Content

Loading ...
Support Center